MedMira Inc.
MMIRF · OTC
7/31/2024 | 7/31/2023 | 7/31/2022 | 7/31/2021 | |
|---|---|---|---|---|
| Revenue | $413 | $433 | $952 | $2,144 |
| % Growth | -4.6% | -54.6% | -55.6% | – |
| Cost of Goods Sold | $186 | $132 | $648 | $423 |
| Gross Profit | $226 | $300 | $304 | $1,722 |
| % Margin | 54.9% | 69.4% | 31.9% | 80.3% |
| R&D Expenses | $477 | $471 | $191 | $359 |
| G&A Expenses | $1,196 | $843 | $735 | $491 |
| SG&A Expenses | $1,479 | $1,039 | $750 | $535 |
| Sales & Mktg Exp. | $283 | $196 | $15 | $44 |
| Other Operating Expenses | $843 | $735 | $0 | $0 |
| Operating Expenses | $2,799 | $2,245 | $1,574 | $1,716 |
| Operating Income | -$2,573 | -$1,944 | -$1,453 | -$184 |
| % Margin | -623.7% | -449.5% | -152.6% | -8.6% |
| Other Income/Exp. Net | -$753 | -$731 | -$378 | -$492 |
| Pre-Tax Income | -$3,326 | -$2,676 | -$1,832 | -$676 |
| Tax Expense | $0 | $0 | $174 | $0 |
| Net Income | -$3,326 | -$2,676 | -$1,832 | -$676 |
| % Margin | -806.2% | -618.6% | -192.4% | -31.5% |
| EPS | -0.005 | -0.004 | -0.003 | -0.001 |
| % Growth | -20% | -48.1% | -170% | – |
| EPS Diluted | -0.005 | -0.004 | -0.003 | -0.001 |
| Weighted Avg Shares Out | 697,666 | 668,915 | 680,646 | 658,327 |
| Weighted Avg Shares Out Dil | 697,666 | 697,446 | 680,646 | 658,327 |
| Supplemental Information | – | – | – | – |
| Interest Income | -$14 | $886 | $552 | $653 |
| Interest Expense | $882 | $0 | $552 | $653 |
| Depreciation & Amortization | $310 | $213 | $212 | $208 |
| EBITDA | -$2,134 | -$1,577 | -$1,067 | $185 |
| % Margin | -517.3% | -364.7% | -112.1% | 8.6% |